secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0001193125-24-113883
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q3 FY2024 revenue $1.20B, +7% YoY; GAAP EPS $2.04, non-GAAP $2.13
------------------------------------------------------------------------

- Revenue $1.197B up 7% YoY (7% constant currency); mask/accessories double-digit growth.
- Gross margin expanded 260 bps to 57.9%; non-GAAP 58.5%.
- Operating profit $374.6M (+25%); non-GAAP operating profit $393.6M (+23%).
- Diluted GAAP EPS $2.04 (+29%); non-GAAP EPS $2.13 (+27%).
- Quarterly dividend $0.48, record May 9, payable June 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312524113883/0001193125-24-113883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312524113883/d817936d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-113883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer